Global Infectious Disease Biomarker Testing Market Growth (Status and Outlook) 2025-2031

September 2025 | 122 pages | ID: G2A5468F02D8EN
LP Information

Abstracts

According to this study, the global Infectious Disease Biomarker Testing market size will reach US$ million by 2031.

United States market for Infectious Disease Biomarker Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Infectious Disease Biomarker Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Infectious Disease Biomarker Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Infectious Disease Biomarker Testing players cover Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies, Becton, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Infectious Disease Biomarker Testing Industry Forecast” looks at past sales and reviews total world Infectious Disease Biomarker Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease Biomarker Testing sales for 2025 through 2031. With Infectious Disease Biomarker Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Biomarker Testing industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease Biomarker Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Biomarker Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Biomarker Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Biomarker Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Biomarker Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Biomarker Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:

• PCR
• NGS
• ELISA or EIA
• IHC
• ISH
• Others

Segmentation by Application:

• Hospitals and Clinics
• Diagnostic Centers
• Academic Research Institutes
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abacus Diagnostica
• ALPCO
• Abbott Laboratories
• Agilent Technologies
• Becton
• Dickinson and Company
• bioM?rieux SA
• Bio-Rad Laboratories
• Danaher
• F. Hoffmann-La Roche
• Hologic
• PerkinElmer
• Qiagen
• Quest Diagnostics Incorporated
• Siemens Healthineers
• Thermo Fisher Scientific

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Infectious Disease Biomarker Testing Market Size (2020-2031)
  2.1.2 Infectious Disease Biomarker Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Infectious Disease Biomarker Testing by Country/Region (2020, 2024 & 2031)
2.2 Infectious Disease Biomarker Testing Segment by Type
  2.2.1 PCR
  2.2.2 NGS
  2.2.3 ELISA or EIA
  2.2.4 IHC
  2.2.5 ISH
  2.2.6 Others
2.3 Infectious Disease Biomarker Testing Market Size by Type
  2.3.1 Infectious Disease Biomarker Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Infectious Disease Biomarker Testing Market Size Market Share by Type (2020-2025)
2.4 Infectious Disease Biomarker Testing Segment by Application
  2.4.1 Hospitals and Clinics
  2.4.2 Diagnostic Centers
  2.4.3 Academic Research Institutes
  2.4.4 Others
2.5 Infectious Disease Biomarker Testing Market Size by Application
  2.5.1 Infectious Disease Biomarker Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Infectious Disease Biomarker Testing Market Size Market Share by Application (2020-2025)

3 INFECTIOUS DISEASE BIOMARKER TESTING MARKET SIZE BY PLAYER

3.1 Infectious Disease Biomarker Testing Market Size Market Share by Player
  3.1.1 Global Infectious Disease Biomarker Testing Revenue by Player (2020-2025)
  3.1.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Player (2020-2025)
3.2 Global Infectious Disease Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INFECTIOUS DISEASE BIOMARKER TESTING BY REGION

4.1 Infectious Disease Biomarker Testing Market Size by Region (2020-2025)
4.2 Global Infectious Disease Biomarker Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Disease Biomarker Testing Market Size Growth (2020-2025)
4.4 APAC Infectious Disease Biomarker Testing Market Size Growth (2020-2025)
4.5 Europe Infectious Disease Biomarker Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Infectious Disease Biomarker Testing Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Infectious Disease Biomarker Testing Market Size by Country (2020-2025)
5.2 Americas Infectious Disease Biomarker Testing Market Size by Type (2020-2025)
5.3 Americas Infectious Disease Biomarker Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Infectious Disease Biomarker Testing Market Size by Region (2020-2025)
6.2 APAC Infectious Disease Biomarker Testing Market Size by Type (2020-2025)
6.3 APAC Infectious Disease Biomarker Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Infectious Disease Biomarker Testing Market Size by Country (2020-2025)
7.2 Europe Infectious Disease Biomarker Testing Market Size by Type (2020-2025)
7.3 Europe Infectious Disease Biomarker Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Infectious Disease Biomarker Testing by Region (2020-2025)
8.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INFECTIOUS DISEASE BIOMARKER TESTING MARKET FORECAST

10.1 Global Infectious Disease Biomarker Testing Forecast by Region (2026-2031)
  10.1.1 Global Infectious Disease Biomarker Testing Forecast by Region (2026-2031)
  10.1.2 Americas Infectious Disease Biomarker Testing Forecast
  10.1.3 APAC Infectious Disease Biomarker Testing Forecast
  10.1.4 Europe Infectious Disease Biomarker Testing Forecast
  10.1.5 Middle East & Africa Infectious Disease Biomarker Testing Forecast
10.2 Americas Infectious Disease Biomarker Testing Forecast by Country (2026-2031)
  10.2.1 United States Market Infectious Disease Biomarker Testing Forecast
  10.2.2 Canada Market Infectious Disease Biomarker Testing Forecast
  10.2.3 Mexico Market Infectious Disease Biomarker Testing Forecast
  10.2.4 Brazil Market Infectious Disease Biomarker Testing Forecast
10.3 APAC Infectious Disease Biomarker Testing Forecast by Region (2026-2031)
  10.3.1 China Infectious Disease Biomarker Testing Market Forecast
  10.3.2 Japan Market Infectious Disease Biomarker Testing Forecast
  10.3.3 Korea Market Infectious Disease Biomarker Testing Forecast
  10.3.4 Southeast Asia Market Infectious Disease Biomarker Testing Forecast
  10.3.5 India Market Infectious Disease Biomarker Testing Forecast
  10.3.6 Australia Market Infectious Disease Biomarker Testing Forecast
10.4 Europe Infectious Disease Biomarker Testing Forecast by Country (2026-2031)
  10.4.1 Germany Market Infectious Disease Biomarker Testing Forecast
  10.4.2 France Market Infectious Disease Biomarker Testing Forecast
  10.4.3 UK Market Infectious Disease Biomarker Testing Forecast
  10.4.4 Italy Market Infectious Disease Biomarker Testing Forecast
  10.4.5 Russia Market Infectious Disease Biomarker Testing Forecast
10.5 Middle East & Africa Infectious Disease Biomarker Testing Forecast by Region (2026-2031)
  10.5.1 Egypt Market Infectious Disease Biomarker Testing Forecast
  10.5.2 South Africa Market Infectious Disease Biomarker Testing Forecast
  10.5.3 Israel Market Infectious Disease Biomarker Testing Forecast
  10.5.4 Turkey Market Infectious Disease Biomarker Testing Forecast
10.6 Global Infectious Disease Biomarker Testing Forecast by Type (2026-2031)
10.7 Global Infectious Disease Biomarker Testing Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Infectious Disease Biomarker Testing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abacus Diagnostica
  11.1.1 Abacus Diagnostica Company Information
  11.1.2 Abacus Diagnostica Infectious Disease Biomarker Testing Product Offered
  11.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abacus Diagnostica Main Business Overview
  11.1.5 Abacus Diagnostica Latest Developments
11.2 ALPCO
  11.2.1 ALPCO Company Information
  11.2.2 ALPCO Infectious Disease Biomarker Testing Product Offered
  11.2.3 ALPCO Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 ALPCO Main Business Overview
  11.2.5 ALPCO Latest Developments
11.3 Abbott Laboratories
  11.3.1 Abbott Laboratories Company Information
  11.3.2 Abbott Laboratories Infectious Disease Biomarker Testing Product Offered
  11.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Abbott Laboratories Main Business Overview
  11.3.5 Abbott Laboratories Latest Developments
11.4 Agilent Technologies
  11.4.1 Agilent Technologies Company Information
  11.4.2 Agilent Technologies Infectious Disease Biomarker Testing Product Offered
  11.4.3 Agilent Technologies Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Agilent Technologies Main Business Overview
  11.4.5 Agilent Technologies Latest Developments
11.5 Becton
  11.5.1 Becton Company Information
  11.5.2 Becton Infectious Disease Biomarker Testing Product Offered
  11.5.3 Becton Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Becton Main Business Overview
  11.5.5 Becton Latest Developments
11.6 Dickinson and Company
  11.6.1 Dickinson and Company Company Information
  11.6.2 Dickinson and Company Infectious Disease Biomarker Testing Product Offered
  11.6.3 Dickinson and Company Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Dickinson and Company Main Business Overview
  11.6.5 Dickinson and Company Latest Developments
11.7 bioM?rieux SA
  11.7.1 bioM?rieux SA Company Information
  11.7.2 bioM?rieux SA Infectious Disease Biomarker Testing Product Offered
  11.7.3 bioM?rieux SA Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 bioM?rieux SA Main Business Overview
  11.7.5 bioM?rieux SA Latest Developments
11.8 Bio-Rad Laboratories
  11.8.1 Bio-Rad Laboratories Company Information
  11.8.2 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Offered
  11.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Bio-Rad Laboratories Main Business Overview
  11.8.5 Bio-Rad Laboratories Latest Developments
11.9 Danaher
  11.9.1 Danaher Company Information
  11.9.2 Danaher Infectious Disease Biomarker Testing Product Offered
  11.9.3 Danaher Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Danaher Main Business Overview
  11.9.5 Danaher Latest Developments
11.10 F. Hoffmann-La Roche
  11.10.1 F. Hoffmann-La Roche Company Information
  11.10.2 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Offered
  11.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 F. Hoffmann-La Roche Main Business Overview
  11.10.5 F. Hoffmann-La Roche Latest Developments
11.11 Hologic
  11.11.1 Hologic Company Information
  11.11.2 Hologic Infectious Disease Biomarker Testing Product Offered
  11.11.3 Hologic Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Hologic Main Business Overview
  11.11.5 Hologic Latest Developments
11.12 PerkinElmer
  11.12.1 PerkinElmer Company Information
  11.12.2 PerkinElmer Infectious Disease Biomarker Testing Product Offered
  11.12.3 PerkinElmer Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 PerkinElmer Main Business Overview
  11.12.5 PerkinElmer Latest Developments
11.13 Qiagen
  11.13.1 Qiagen Company Information
  11.13.2 Qiagen Infectious Disease Biomarker Testing Product Offered
  11.13.3 Qiagen Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Qiagen Main Business Overview
  11.13.5 Qiagen Latest Developments
11.14 Quest Diagnostics Incorporated
  11.14.1 Quest Diagnostics Incorporated Company Information
  11.14.2 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Offered
  11.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Quest Diagnostics Incorporated Main Business Overview
  11.14.5 Quest Diagnostics Incorporated Latest Developments
11.15 Siemens Healthineers
  11.15.1 Siemens Healthineers Company Information
  11.15.2 Siemens Healthineers Infectious Disease Biomarker Testing Product Offered
  11.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Siemens Healthineers Main Business Overview
  11.15.5 Siemens Healthineers Latest Developments
11.16 Thermo Fisher Scientific
  11.16.1 Thermo Fisher Scientific Company Information
  11.16.2 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Offered
  11.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Thermo Fisher Scientific Main Business Overview
  11.16.5 Thermo Fisher Scientific Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Infectious Disease Biomarker Testing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Infectious Disease Biomarker Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of PCR
Table 4. Major Players of NGS
Table 5. Major Players of ELISA or EIA
Table 6. Major Players of IHC
Table 7. Major Players of ISH
Table 8. Major Players of Others
Table 9. Infectious Disease Biomarker Testing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Infectious Disease Biomarker Testing Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Infectious Disease Biomarker Testing Market Size Market Share by Type (2020-2025)
Table 12. Infectious Disease Biomarker Testing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Infectious Disease Biomarker Testing Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Infectious Disease Biomarker Testing Market Size Market Share by Application (2020-2025)
Table 15. Global Infectious Disease Biomarker Testing Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Infectious Disease Biomarker Testing Revenue Market Share by Player (2020-2025)
Table 17. Infectious Disease Biomarker Testing Key Players Head office and Products Offered
Table 18. Infectious Disease Biomarker Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Infectious Disease Biomarker Testing Market Size Market Share by Region (2020-2025)
Table 23. Global Infectious Disease Biomarker Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Infectious Disease Biomarker Testing Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Infectious Disease Biomarker Testing Market Size Market Share by Country (2020-2025)
Table 27. Americas Infectious Disease Biomarker Testing Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Infectious Disease Biomarker Testing Market Size Market Share by Type (2020-2025)
Table 29. Americas Infectious Disease Biomarker Testing Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Infectious Disease Biomarker Testing Market Size Market Share by Application (2020-2025)
Table 31. APAC Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Infectious Disease Biomarker Testing Market Size Market Share by Region (2020-2025)
Table 33. APAC Infectious Disease Biomarker Testing Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Infectious Disease Biomarker Testing Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Infectious Disease Biomarker Testing Market Size Market Share by Country (2020-2025)
Table 37. Europe Infectious Disease Biomarker Testing Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Infectious Disease Biomarker Testing Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Infectious Disease Biomarker Testing
Table 43. Key Market Challenges & Risks of Infectious Disease Biomarker Testing
Table 44. Key Industry Trends of Infectious Disease Biomarker Testing
Table 45. Global Infectious Disease Biomarker Testing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Infectious Disease Biomarker Testing Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Infectious Disease Biomarker Testing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Infectious Disease Biomarker Testing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Abacus Diagnostica Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 50. Abacus Diagnostica Infectious Disease Biomarker Testing Product Offered
Table 51. Abacus Diagnostica Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Abacus Diagnostica Main Business
Table 53. Abacus Diagnostica Latest Developments
Table 54. ALPCO Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 55. ALPCO Infectious Disease Biomarker Testing Product Offered
Table 56. ALPCO Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. ALPCO Main Business
Table 58. ALPCO Latest Developments
Table 59. Abbott Laboratories Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 60. Abbott Laboratories Infectious Disease Biomarker Testing Product Offered
Table 61. Abbott Laboratories Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Abbott Laboratories Main Business
Table 63. Abbott Laboratories Latest Developments
Table 64. Agilent Technologies Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 65. Agilent Technologies Infectious Disease Biomarker Testing Product Offered
Table 66. Agilent Technologies Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Agilent Technologies Main Business
Table 68. Agilent Technologies Latest Developments
Table 69. Becton Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 70. Becton Infectious Disease Biomarker Testing Product Offered
Table 71. Becton Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Becton Main Business
Table 73. Becton Latest Developments
Table 74. Dickinson and Company Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 75. Dickinson and Company Infectious Disease Biomarker Testing Product Offered
Table 76. Dickinson and Company Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Dickinson and Company Main Business
Table 78. Dickinson and Company Latest Developments
Table 79. bioM?rieux SA Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 80. bioM?rieux SA Infectious Disease Biomarker Testing Product Offered
Table 81. bioM?rieux SA Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. bioM?rieux SA Main Business
Table 83. bioM?rieux SA Latest Developments
Table 84. Bio-Rad Laboratories Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 85. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Offered
Table 86. Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Bio-Rad Laboratories Main Business
Table 88. Bio-Rad Laboratories Latest Developments
Table 89. Danaher Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 90. Danaher Infectious Disease Biomarker Testing Product Offered
Table 91. Danaher Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Danaher Main Business
Table 93. Danaher Latest Developments
Table 94. F. Hoffmann-La Roche Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 95. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Offered
Table 96. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. F. Hoffmann-La Roche Main Business
Table 98. F. Hoffmann-La Roche Latest Developments
Table 99. Hologic Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 100. Hologic Infectious Disease Biomarker Testing Product Offered
Table 101. Hologic Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Hologic Main Business
Table 103. Hologic Latest Developments
Table 104. PerkinElmer Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 105. PerkinElmer Infectious Disease Biomarker Testing Product Offered
Table 106. PerkinElmer Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. PerkinElmer Main Business
Table 108. PerkinElmer Latest Developments
Table 109. Qiagen Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 110. Qiagen Infectious Disease Biomarker Testing Product Offered
Table 111. Qiagen Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. Qiagen Main Business
Table 113. Qiagen Latest Developments
Table 114. Quest Diagnostics Incorporated Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 115. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Offered
Table 116. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Quest Diagnostics Incorporated Main Business
Table 118. Quest Diagnostics Incorporated Latest Developments
Table 119. Siemens Healthineers Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 120. Siemens Healthineers Infectious Disease Biomarker Testing Product Offered
Table 121. Siemens Healthineers Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 122. Siemens Healthineers Main Business
Table 123. Siemens Healthineers Latest Developments
Table 124. Thermo Fisher Scientific Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 125. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Offered
Table 126. Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 127. Thermo Fisher Scientific Main Business
Table 128. Thermo Fisher Scientific Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Infectious Disease Biomarker Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Biomarker Testing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Infectious Disease Biomarker Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Infectious Disease Biomarker Testing Sales Market Share by Country/Region (2024)
Figure 8. Infectious Disease Biomarker Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Infectious Disease Biomarker Testing Market Size Market Share by Type in 2024
Figure 10. Infectious Disease Biomarker Testing in Hospitals and Clinics
Figure 11. Global Infectious Disease Biomarker Testing Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. Infectious Disease Biomarker Testing in Diagnostic Centers
Figure 13. Global Infectious Disease Biomarker Testing Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Infectious Disease Biomarker Testing in Academic Research Institutes
Figure 15. Global Infectious Disease Biomarker Testing Market: Academic Research Institutes (2020-2025) & ($ millions)
Figure 16. Infectious Disease Biomarker Testing in Others
Figure 17. Global Infectious Disease Biomarker Testing Market: Others (2020-2025) & ($ millions)
Figure 18. Global Infectious Disease Biomarker Testing Market Size Market Share by Application in 2024
Figure 19. Global Infectious Disease Biomarker Testing Revenue Market Share by Player in 2024
Figure 20. Global Infectious Disease Biomarker Testing Market Size Market Share by Region (2020-2025)
Figure 21. Americas Infectious Disease Biomarker Testing Market Size 2020-2025 ($ millions)
Figure 22. APAC Infectious Disease Biomarker Testing Market Size 2020-2025 ($ millions)
Figure 23. Europe Infectious Disease Biomarker Testing Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Infectious Disease Biomarker Testing Market Size 2020-2025 ($ millions)
Figure 25. Americas Infectious Disease Biomarker Testing Value Market Share by Country in 2024
Figure 26. United States Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Infectious Disease Biomarker Testing Market Size Market Share by Region in 2024
Figure 31. APAC Infectious Disease Biomarker Testing Market Size Market Share by Type (2020-2025)
Figure 32. APAC Infectious Disease Biomarker Testing Market Size Market Share by Application (2020-2025)
Figure 33. China Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 37. India Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Infectious Disease Biomarker Testing Market Size Market Share by Country in 2024
Figure 40. Europe Infectious Disease Biomarker Testing Market Size Market Share by Type (2020-2025)
Figure 41. Europe Infectious Disease Biomarker Testing Market Size Market Share by Application (2020-2025)
Figure 42. Germany Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 43. France Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Infectious Disease Biomarker Testing Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 56. APAC Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 57. Europe Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 59. United States Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 60. Canada Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 61. Mexico Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 62. Brazil Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 63. China Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 64. Japan Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 65. Korea Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 67. India Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 68. Australia Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 69. Germany Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 70. France Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 71. UK Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 72. Italy Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 73. Russia Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 74. Egypt Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 75. South Africa Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 76. Israel Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 77. Turkey Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)
Figure 78. Global Infectious Disease Biomarker Testing Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Infectious Disease Biomarker Testing Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Infectious Disease Biomarker Testing Market Size 2026-2031 ($ millions)